Delivery Order SPE2DR25D2101-SPE2DR26F46TS
- Not listed
- The Defense Logistics Agency awarded a $119,604.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and designates Conshohocken, Pennsylvania as the place of performance, which serves as AmerisourceBergen's corporate headquarters. The delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,945.72 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This firm fixed-price delivery order, which is a child contract under a larger vehicle, carries an ultimate completion date of December 9, 2025 and involves no set-aside designation, indicating it was competitively awarded. The work will be performed at the...
- The Defense Logistics Agency awarded a $126,044.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product, with an ultimate completion date of January 2, 2026. This is a firm fixed-price delivery order issued without a set-aside designation, reflecting competitive procurement practices. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 18, 2025. This competitive award, issued under a firm fixed-price delivery order contract with no set-aside designation, represents a single transaction on AmerisourceBergen's larger pharmaceutical supply agreement with the agency. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,601.98 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by December 9, 2025, with the place of performance at the company's Conshohocken facility. The award was made through competitive procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,487.29 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, valued at $11,960.40. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 26, 2025. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,606.72 by the Defense Logistics Agency's Medical Supply Chain on August 2, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, is scheduled for completion by August 4, 2025 and represents a non-competitively set-aside award. The work will be performed at the vendor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,363.21 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being fulfilled at the vendor's corporate office location in Conshohocken, PA. The delivery order is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,839.64 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46TSDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $31,511.05 for DARZALEX FASPRO 1,800MG-30,000 15ML. Awarded on December 22, 2025, with an ultimate completion date of January 14, 2026, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The product will be delivered to the contractor's location in Conshohocken, PA, supporting the federal government's pharmaceutical procurement needs. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency on a global basis. The company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement, combined with its extensive pharmaceutical portfolio, positions it as a critical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.5k | 12/21/25 |